新型自诱导剂通过加快对帕金森病的溶酶体聚类来预防帕金森病
Yuki Date1,2, Yukiko Sasazawa2,3,4, Mitsuhiro Kitagawa2
1Department of Biology, Graduate School of Science and Engineering, Chiba University, Inage-ku, Chiba, Japan.
eLife
|June 20, 2024
概括
研究人员确定了聚合溶酶体的药物,增强了蛋白质聚合物的降解. 这种方法对治疗神经退行性疾病,如帕金森病,通过清除有毒蛋白质团块,显示出前景.
科学领域:
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 自-溶酶体通路对于清除异常蛋白质至关重要,如阿尔法-同核素 (αSyn),与帕金森病 (PD) 有关.
- 目前的策略往往侧重于 lysosomal 酶活性,忽视了由 lysosomal 定位在微管组织中心 (MTOC) 附近调节的自菌体-lysosome 融合过程.
研究的目的:
- 通过在MTOC周围诱导 lysosomal 聚类来促进自菌体-溶解体融合的化合物.
- 研究溶酶体聚类化合物在清除神经退行性疾病相关的蛋白质聚合物的治疗潜力.
主要方法:
- 1200种临床批准药物的高通量化学选.
- 评估 lysosomal 定位,自流和蛋白质聚合物的降解 (Triton-X 不溶性和蛋白质酶体抑制剂诱导).
- 调查JIP4-TRPML1途径在调解 lysosomal 集群中的作用.
主要成果:
- 确定了六种化合物,可诱导MTOC周围的溶酶体聚类,并增强自流.
- 这些化合物,包括阿尔本达,通过一个依赖于JIP4-TRPML1的机制促进 lysosomal 聚类.
- 阿尔本达在细胞PD模型中增强了蛋白质聚合物和不溶性αSyn的降解.
结论:
- Lysosomal 聚类是一种可行的策略,可以增强有毒蛋白质聚合物的降解.
- 像阿尔本达这样的溶酶体聚类化合物代表了蛋白质病变和神经退行性疾病 (如PD) 的有前途的治疗途径.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.5K
09:29Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
7.2K
相关概念视频
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment
255
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
255
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Parkinson's Disease: Overview
524
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
524
Delivery Pathways to the Lysosome
6.3K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.3K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
